NCM Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

NCM Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$215K	Hold	428	–	–	0.07%	183
2026 Q1	$210K	Hold	428	–	–	0.08%	179
2025 Q4	$248K	Hold	428	–	–	0.09%	163
2025 Q3	$208K	Buy	+428	New	+$199K	0.08%	175
2025 Q2	–	Sell	-495	Closed	-$246K	–	180
2025 Q1	$246K	Hold	495	–	–	0.11%	154
2024 Q4	$258K	Hold	495	–	–	0.12%	149
2024 Q3	$306K	Hold	495	–	–	0.15%	131
2024 Q2	$274K	Hold	495	–	–	0.14%	132
2024 Q1	$288K	Sell	495 -2	-0.4%	-$1.12K	0.16%	128
2023 Q4	$264K	Buy	497 +59	+13%	+$28.6K	0.16%	132
2023 Q3	$222K	Buy	+438	New	+$233K	0.16%	136

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NCM Capital Management's TMO Position: Q2 2026 in Review

NCM Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 428 shares worth $215K. The position accounts for 0.07% of the portfolio, ranked #183.

NCM Capital Management first reported a position in TMO in Q3 2023 and has held it in 11 quarters since. The position peaked at $306K in Q3 2024. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

NCM Capital Management held 428 shares of Thermo Fisher Scientific worth $215K as of Q2 2026.
NCM Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.07% of NCM Capital Management's portfolio in Q2 2026, its #183 holding.
NCM Capital Management first reported a position in Thermo Fisher Scientific in Q3 2023 and has held it in 11 quarters since.
NCM Capital Management's Thermo Fisher Scientific position peaked at $306K in Q3 2024.
2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on NCM Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.